Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Paediatric Drugs|April 19, 2002
Ethical issues in including pediatric cancer patients in drug development trialsKatarina Aleksa, Gideon KorenCritical Reviews in Clinical Laboratory Sciences|July 2, 2020
What the lab can and cannot do: clinical interpretation of drug testing resultsBhushan M Kapur, Katarina AleksaCanadian Journal of Physiology and Pharmacology|August 24, 2011
Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicityPatrina Gunness, Katarina Aleksa, Gideon KorenThe Journal of Laboratory and Clinical Medicine|March 10, 2004
Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levelsKatarina Aleksa, Shinya Ito, Gideon KorenChirality|April 1, 2006
Enantioselective metabolism of ifosfamide by the kidneyKatarina Aleksa, Shinya Ito, Gideon KorenToxicology Letters|January 10, 2012
Hair as a biomarker of polybrominated diethyl ethers' exposure in infants, children and adultsKatarina Aleksa, Jyrki Liesivuori, Gideon KorenJournal of Translational Medicine|January 4, 2011
The effect of acyclovir on the tubular secretion of creatinine in vitroPatrina Gunness, Katarina Aleksa, Gideon KorenChirality|October 1, 2008
Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MSKatarina Aleksa, Alejandro Nava-Ocampo, Gideon KorenForensic Science International|November 15, 2011
Detection of polybrominated biphenyl ethers (PBDEs) in pediatric hair as a tool for determining in utero exposureKatarina Aleksa, Amanda Carnevale, Cynthia Goodyer, et al.Canadian Journal of Physiology and Pharmacology|July 29, 2005
A tubule cell model for ifosfamide nephrotoxicityKatarina Aleksa, Naomi Halachmi, Shinya Ito, et al.Pageof 4